Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products-Reference-Cited by-同舟云学术

Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products

Published:2009-05 Issue:1 Volume:72 Page:91-98
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Okumu Arthur,DiMaso Marie,Löbenberg Raimar

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference32 articles.

1. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2;Riendeau;J. Pharmacol. Exp. Ther.,2001

2. Etoricoxib;Cochrane;Drugs,2002

3. Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man;Agrawal;J. Clin. Pharmacol.,2003

4. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms;Dressman;Pharm. Res.,1998

5. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms;Siewert;AAPS PharmSciTech,2003

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel First-Generation Dissolution Models to Investigate the Release and Uptake of Oral Lymphotropic Drug Products;AAPS PharmSciTech;2024-08-14

2. Supramolecular interactions in cocrystals of benzoic acid derivatives with selective COX-2 inhibitor etoricoxib;Acta Crystallographica Section C Structural Chemistry;2024-07-05

3. Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report;Molecular Pharmaceutics;2024-07-01

4. In-silico design novel phenylsulfonyl furoxan and phenstatin derivatives as multi-target anti-cancer inhibitors based on 2D-QSAR, molecular docking, dynamics and ADMET approaches;Molecular Simulation;2024-03-13

5. Computer-aided biopharmaceutical characterization: Gastrointestinal absorption simulation;Computer-Aided Applications in Pharmaceutical Technology;2024